David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Bitwise Crypto Industry Innovators ETF
BITQ
$422M
| $786K | ﹤0.01% |
32,066
-4,532
| -12% | -$115K |
|
3802
Limoneira
LMNR
$251M
| $785K | ﹤0.01% |
59,786
-4,555
| -7% | -$58.7K |
|
3803
MSCI
MSCI
$41B
| $784K | ﹤0.01% |
+1,400
| New | +$817K |
|
3804
PUT
Sibanye-Stillwater
SBSW
$8.9B
| $784K | ﹤0.01% |
92,300
| – | – |
|
3805
CALL
Xerox
XRX
$381M
| $783K | ﹤0.01% |
250,000
| – | – |
|
3806
PUT
Unusual Machines
UMAC
$1.37B
| $781K | ﹤0.01% |
+35,000
| New | +$648K |
|
3807
Westrock Coffee
WEST
$812M
| $780K | ﹤0.01% |
96,160
+63,945
| +198% | +$459K |
|
3808
CALL
WD-40
WDFC
$2.91B
| $780K | ﹤0.01% |
+3,200
| New | +$685K |
|
|
WYFI
3809
CALL
WhiteFiber Inc
WYFI
$805M
| $777K | ﹤0.01% |
+20,000
| New | +$484K |
|
3810
CALL
Nektar Therapeutics
NKTR
$2.53B
| $775K | ﹤0.01% |
+11,100
| New | +$812K |
|
3811
IDEAYA Biosciences
IDYA
$3.83B
| $774K | ﹤0.01% |
+20,763
| New | +$636K |
|
3812
Mistras Group
MG
$604M
| $773K | ﹤0.01% |
44,226
-41,805
| -49% | -$744K |
|
3813
Life Time Group Holdings
LTH
$10.1B
| $772K | ﹤0.01% |
18,900
-308,118
| -94% | -$9.78M |
|
3814
ADC Therapeutics
ADCT
$127M
| $770K | ﹤0.01% |
719,320
+476,144
| +196% | +$1.39M |
|
|
OPTU
3815
Optimum Communications Inc
OPTU
$323M
| $769K | ﹤0.01% |
530,505
-8,042,664
| -94% | -$10M |
|
3816
Riskified
RSKD
$779M
| $767K | ﹤0.01% |
152,211
-126,088
| -45% | -$588K |
|
3817
PUT
Halozyme
HALO
$12.3B
| $767K | ﹤0.01% |
9,800
| – | – |
|
3818
PUT
Vishay Precision Group
VPG
$887M
| $765K | ﹤0.01% |
+5,100
| New | +$473K |
|
3819
GrowGeneration
GRWG
$101M
| $762K | ﹤0.01% |
514,602
+134,340
| +35% | +$190K |
|
|
GAP
3820
The Gap Inc
GAP
$7.13B
| $760K | ﹤0.01% |
40,705
-481,179
| -92% | -$11.1M |
|
3821
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.12B
| $760K | ﹤0.01% |
+5,642
| New | +$737K |
|
3822
PUT
Procore
PCOR
$9.65B
| $760K | ﹤0.01% |
18,700
-30,200
| -62% | -$1.49M |
|
3823
PUT
Pilgrim's Pride
PPC
$7.68B
| $759K | ﹤0.01% |
+27,000
| New | +$830K |
|
3824
Univest Financial
UVSP
$1.15B
| $758K | ﹤0.01% |
17,330
-1,423
| -8% | -$55.7K |
|
3825
Relmada Therapeutics
RLMD
$494M
| $758K | ﹤0.01% |
+109,474
| New | +$765K |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.